İpEk Polat

İpEk Polat

Auto-generated profile, based on publicly available information

İpEk Polat

Dokuz Eylül University Faculty of Medicine, Department of Pediatric Neurology, İzmir, Türkiye

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
IPİpek Polat
İpek Polat
UYUluç Yiş
Uluç Yiş
MAMüge Ayanoğlu
Müge Ayanoğlu
DODerya Okur
Derya Okur
PEPınar Edem
Pınar Edem
SKSemra Hız Kurul
Semra Hız Kurul

22 May 2020 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
IPİpEk Polat
İpEk Polat
SMSerap Cilaker Mıcılı
Serap Cilaker Mıcılı
MÇMeryem Çalışır
Meryem Çalışır
EBErhan Bayram
Erhan Bayram
UYUluç Yiş
Uluç Yiş
SKSemra Hız Kurul
Semra Hız Kurul

1 May 2016 in Pediatrics
Verified
Journal Article
Closed access
IPİpEk Polat
İpEk Polat
UYUluç Yiş
Uluç Yiş
PKPakize Karaoğlu
Pakize Karaoğlu
MAMuge Ayanoğlu
Muge Ayanoğlu
TÖTülay Öztürk
Tülay Öztürk
SKSemra Hız Kurul
Semra Hız Kurul
Myelin oligodendrocyte glycoprotein (MOG) is a candidate target antigen in demyelinating central nervous system diseases, including acute disseminated encephalomyelitis (ADEM), neuromyelitis optica, and multiple sclerosis. It may give prognostic information regarding monophasic or recurrent course of the disease. MOG antibodies have been shown to be positive in high titers during the first episode of ADEM with rapidly decreasing to undetectable limits after recovery. However, persistent MOG antibodies are considered as a predicting factor for multiple sclerosis, optic neuritis relapses, and incomplete recovery of ADEM. Here we report a unique case with persistent MOG antibodies presented with multiphasic ADEM-like attacks. A 6-year-old girl was consulted with encephalopathy, gait disturbance, and oculomotor nerve palsy. Periventricular white matter lesions were seen on cranial magnetic resonance imaging studies. ADEM was diagnosed and treated with steroid. During follow-up, she experienced repeated episodes after steroid therapy termination. We were able to search MOG antibody at the ninth attack. The positivity of this antibody remained. It was thought to be associated with steroid-dependent course, and azathioprine and intravenous human immunoglobulin treatment were added. Patients with persistent MOG antibodies may benefit from addition of immunosuppressant agents, which may decrease the number of attacks.

1 January 2022 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
IPİpEk Polat
İpEk Polat
PKPakize Karaoğlu
Pakize Karaoğlu
AŞAli Rıza Şişman
Ali Rıza Şişman
UYUluç Yiş
Uluç Yiş
SKSemra Hız Kurul
Semra Hız Kurul

25 June 2017 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
UYUluç Yiş
Uluç Yiş
VDVishal Dixit
Vishal Dixit
SISedat Işıkay
Sedat Işıkay
MKMert Karakaya
Mert Karakaya
FBFigen Baydan
Figen Baydan
SÇSebahattin Çırak
Sebahattin Çırak
Laminin α2 related congenital muscular dystrophy is one of the most common congenital muscular dystrophies of childhood with or without clinical evidence of central nervous system involvement. It may be associated with significant white matter abnormalities resembling leukodystrophies. In this study, we elaborated on two cases with laminin α2 related congenital muscular dystrophy who had occipital cortex dysgenesis in addition to characteristic white matter abnormalities. Although laminin α2 related congenital muscular dystrophy with white matter abnormalities is known, the association with occipital cortex dysplasia has been not well recognized by clinical colleagues.

14 March 2015 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
IPİpEk Polat
İpEk Polat
PKPakize Karaoglu
Pakize Karaoglu
MAMuge Ayanoglu
Muge Ayanoglu
UYUluc Yis
Uluc Yis
SHSemra Hiz
Semra Hiz